Sickle Cell Anemia Research Paper

Sickle cell anemia is a hereditary disorder that mostly affects people of African ancestry, but also occurs in other ethnic groups, including people who are of Mediterranean and Middle Eastern descent. More than 70,000 Americans have sickle cell anemia. And about 2 million Americans - and one in 12 African Americans - have sickle cell trait (this means they carry one gene for the disease, but do not have the disease itself).

This mutation paper is to give information on the Sickle Cell disease. This is a negative disease to have because the Sickle Cell Disease decreases the health of the person that has the disease and limits what they can and cannot do. Sickle Cell Disease is a red blood cell disease that causes ab normal hemoglobin to from in the veins. Hemoglobin is the protein that carries oxygen throughout the body to help with the respiratory system. The cause of the genetic mutation is inheritance or getting the disease from the parents the disease is found on chromosome 13 while the hemoglobin is still in beta phase on gene HB A. The disease typically shows symptoms within the first 5 to 6 months of birth and being diagnosed with Sickle Cell Disease. The symptoms include painful swelling on the hands and feet, and Jaundice, which causes a white color to form under the eyes, and turns the skin color yellow.

The main thing doctors do to treat sickle-cell anemia is to avoid complications. They measure the patient’s height and weight to make sure they are growing properly. The doctors also monitor blood pressure to prevent strokes. Doctors also do blood and urine tests to see if there is organ damage or kidney problems. They also do TCD testing or brain ultrasounds to prevent strokes. They also do eye examines to prevent loss of vision. Sickle-cell anemia is caused only by having two mutated hemoglobin genes.

Complications of sickle cell anemia are pain crisis, infection, acute chest syndrome, splenic sequestration, vision loss, leg ulcers, stroke, deep vein thrombosis and pulmonary embolism. Pain crisis is a feeling of pain that can happen all of the sudden with mild to severe intensity and last for a period of time (“Facts About Sickle Cell Disease,” 2016). Serious bacterial infections are potential life threatening due to the damage to the spleen in some people who have sickle cell anemia (https://www.nhlbi.nih.gov/health/health-topics/topics/sca/signs). Acute chest syndrome can be life threatening and symptoms included chest pain, coughing, difficulty breathing, and fever. Splenic sequestration is can be life threatening

Sickle cell anemia (SCA) is an inherited blood disease which causes normal, round, healthy red blood cells to transform into sickle-shaped cells. Normal red blood cells are flexible and can easily pass through capillaries to bring oxygen to different parts of the body. However, sickle cells are fragile, and can easily die, leading to anemia (red blood cell deficiency). SCA can also cause blood vessel occlusion (blockage of blood vessels), tissue infarctions (death due to lack of oxygen), bone, joint, and abdominal pain, yellow eyes and skin, pale skin, delayed growth, increased risk of infections, and damage to organs. The disease is passed on by autosomal recessive inheritance, which means both parents of a child must have the defective gene for the child to be affected. If only one gene is inherited, the victim becomes a carrier of the sickle cell trait, producing only some sickle cells with little or no symptoms. This means two people with the trait have a 25% chance of having a baby with sickle cell disease, 25% chance of them having no defects, and 50% chance of the baby becoming a carrier as well. When the gene is inherited, it mutates the beta (β) globin gene in chromosome 11, changing the hemoglobins produced using instructions from the gene from a healthy hemoglobin A (Hb A) to a mutated hemoglobin S (Hb S). Many tests can be done to check for sickle cell disease, the most common being an ordinary blood test, where the blood is examined for hemoglobin S. If the

Blood transfusions are another option. This can increase the number of red blood cells that cause anemia and makes the body weak and it can fight off other complications from the disease. Gene therapy is a newer treatment that inserts a normal gene into the bone marrow of a person with sickle cell anemia hoping for a result of normal hemoglobin but this process is still in an experimental stage.

Prevalence of Sickle Cell Anemia: Sickle cell anemia is the most common inherited blood disorder in the United States, affecting about 72,000 Americans or 1 in 500 African Americans.

The main goal for treating sickle cell anemia is to help prevent and reduce pain, and to help prevent infections. Other treatments help prevent any organ damage and strokes related to sickle cell anemia causes. To prevent pain, those with more severe conditions use hydroxyurea, a medicine that helps prevent painful crises, not to help when they occur. Mild pain can usually be treated with over the counter medication. More severe pain episodes need hospitalization. Bacterial infections can be a very serious complication for those with sickle cell anemia. To prevent infections in children and babies, doses of penicillin are needed, and all routine vaccinations. Many of the other symptoms and complications of sickle cell anemia are treated with blood transfusions. Blood is taken from a healthy individual and the red blood cells are thus transfused into the individual with sickle cell anemia.

Sickle Cell Disease occurs most commonly in individuals whose families descend from West Africa, South or Central America (particularly Panama), Caribbean islands, Mediterranean nations, (for example, Turkey, Greece, and Italy), India, and Saudi Arabia. In the United States, it’s estimated that Sickle cell affects between 70,000–100,000 individuals, predominately African

Sickle cell disease is a chronic condition that a person can inherit from their parents in which it effects the globular structure of the patients red blood cells. A more sickle shaped structure, which can alter a person’s blood flow, replaces the more common globular structure. This impairment in blood flow can lead to blood clots, severe debilitating pain and damage to vital organs such as the liver, kidney and spleen. This disease currently affects over 90,000 people in the United States, with the majority of them being African American and

Sickle cell anemia has a less serious condition known as Sickle Cell traits. This is a heterozygous condition where less than half of the number of red blood cells is sickle shaped while the rest are normal and they are involved inefficient oxygen loading. An individual with the sickle cell trait experiences a mild case of anemia but always leads a normal life. Treatments that have been prescribed for the sickle cell condition include medication as well as blood transfusions and rarely a bone-marrow

Sickle Cell Disease is a genetic disease caused by a SNP (Single Nucleotide Polymorphism). Which means it is caused by a single letter gene mutation. Through the advent of CRISPR/Cas9 the disease might be cured. It is a serious reality and will enter medical trials within a handful of years. Sickle Cell Disease is an inherited disease that predominantly affects people of African descent. Red Blood cells become rigid and sickle shaped, causing blockages and pain crises. In cases of Sickle Cell Disease the Beta-Globin are mutated causing faulty and deformed Hemoglobin proteins thus creating sickled and short-lived Red Blood Cells.

Sickle Cell Anemia is a hereditary disease that changes the smallest and most important components of the body. A gene causes the bone marrow in the body to make sickled shapes, when this happens; it causes the red blood cell to die faster. This is what causes Hemolytic Anemia. Older children and adults with sickle cell disease may experience a few complications, or have a pattern of ongoing problems that shorten their lives. The most common and serious complications of sickle cell disease are anemia, pain, fatigue, and organ failure. Today there are many alternatives and opportunities that a sickle cell patient may consider. One outlined in this paper is the Hydroxyurea method.

Sickle cell disease is a genetic disease that caused by abnormalities in the production of hemoglobin of red blood cells, characterized by its sickle-like shape. While the main function of hemoglobin in red blood cells is to carry oxygen to different parts of the body, these sickle cells are unable to perform this task adequately. The sickle shape of these red blood cells contributes to lower blood flow through vessels as they begin to build up and block passage through smaller blood vessels (“Facts About Sickle”). Although there are several types of sickle cell diseases, the most severe and common form is sickle cell anemia. Sickle cell anemia is a form of this disease where a child inherits one sickle cell gene from each parent and therefore

Sickle Cell Anemia is a group of disorders that cause red blood cells to become misshapen and break down. Sickle cell disease is the most common inherited blood disorder in the United States, affecting 70,000 to 80,000 Americans (Ashley-Koch, Yang and Olney). Sickle Cell Anemia causes your red blood cells to be thin, stiff, and shaped like a sickle. But your red blood cells are supposed to be round and soft. A person that is diagnosed with sickle cell anemia, their blood cells start to become clogged, causing blood clots, which can cause a great amount of health issues including: infections, stroke, and acute chest syndrome. People get sickle cell anemia by inheriting a mutated gene from both of their parents. On the down side, there is not currently an effective cure for sickle cell anemia, there are several different therapeutic approaches to treating and attempting to cure the disease and help people who are affected with sickle cell anemia better manage their symptoms. There have also been several great scientists that dedicated a lot of research to help find a cure for sickle cell anemia.